Gabriel S Lerman

Title: Gabriel S. Lerman: Innovator in SNORF Receptor Technologies

Introduction

Gabriel S. Lerman is a notable inventor based in Teaneck, NJ (US). He has made significant contributions to the field of molecular biology, particularly in the area of receptor technologies. His work has implications for understanding and treating various abnormalities linked to specific receptors.

Latest Patents

Gabriel S. Lerman holds 1 patent for his invention titled "Processes for obtaining compounds employing SNORF72 receptors." This patent provides isolated nucleic acids encoding mammalian SNORF62 and SNORF72 receptors, as well as purified versions of these receptors. The invention includes vectors comprising nucleic acids, cells containing such vectors, and antibodies directed to the receptors. Additionally, it outlines methods for isolating these receptors and treating abnormalities associated with their activity.

Career Highlights

Lerman is currently associated with H. Lundbeck A/S, a company known for its focus on brain diseases. His work at Lundbeck has allowed him to explore innovative solutions in receptor biology, contributing to advancements in therapeutic approaches.

Collaborations

Some of his notable coworkers include James A. Bonini and Kristine L. Ogozalek. Their collaborative efforts have further enhanced the research and development of receptor-related technologies.

Conclusion

Gabriel S. Lerman's contributions to the field of receptor technologies exemplify the impact of innovative research on medical science. His work continues to pave the way for new treatments and understanding of receptor functions.